how does glp-1 work Why are agonists being used to treat patients with nonalcoholic fatty liver disease? Part 1 of a 3-Part

Description

As these GLP-1 drugs become more prominent, balancing the evident public interest with concerns and ethical distribution will be pivotal in their narrative moving forward

Dietary supplements are not intended to treat, diagnose, cure, or prevent disease

Pathway 1 GLP-1 (Retatrutide) GLP-1 receptor activation in the hypothalamus and nucleus of the solitary tract (NTS) drives appetite suppression and slowed gastric emptying

Exenatide extended-release for injectable suspension

The findings inform opportunities for randomized trials to study SGLT2 inhibitors as potential treatments to mitigate dementia risk in an older population